MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
MAIA Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.07−0.03 (-2.73%)
Close on Oct 19, 2026
- Market cap
- $65.05M
- P/E (TTM)
- –
- Dividend yield
- –
MAIA Biotechnology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Market Cap | $65.08M | $166.30M |
| Enterprise Value | $65.08M | $88.19M |
| PB Ratio | 3.15 | 2.03 |
| P/TBV Ratio | 3.15 | 2.29 |
Income (trailing twelve months)
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Operating Income | -$28.95M | -$21.40M |
| Net Income | -$26.85M | -$22.46M |
| EBITDA | -$28.95M | -$16.91M |
| EPS (Diluted) | -$0.64 | -$0.83 |
Returns
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -218.7% | -53.2% |
| Return on Assets (ROA) | -136.7% | -40.9% |
| Return on Invested Capital (ROIC) | -186.3% | -32.4% |
| Return on Capital Employed (ROCE) | -131.7% | -38.1% |
Balance sheet
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $0 | $61.43M |
| Net Cash (Debt) | $0 | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | $20.68M | $49.09M |
| Book Value Per Share | $0.34 | $1.37 |
| Tangible Book Value | $20.68M | $23.52M |
| Working Capital | $21.98M | $76.81M |
Financial position
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Current Ratio | 4.51 | 3.34 |
| Quick Ratio | 0.00 | 2.44 |
Cash flow (trailing twelve months)
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Operating Cash Flow | -$22.57M | -$12.35M |
Efficiency
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Profits Per Employee | -$2.07M | -$703.34K |
| Employee Count | 13 | 74 |
Dividends and yields
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Earnings Yield | -41.2% | -23.3% |
Shares
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Shares Outstanding | 60,825,800 | 58,127,000 |
| Shares Change (YoY) | 65.0% | 10.9% |
| Shares Change (QoQ) | 0.24% | 0.54% |
| Float | 51,613,500 | 49,136,700 |
| Shares Held by Insiders | 15.1% | 11.6% |
| Shares Held by Institutions | 22.2% | 59.4% |
Scores
| Measure | MAIA Biotechnology | Industry median |
|---|---|---|
| Altman Z-Score | -3.43 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from MAIA Biotechnology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.